NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $9,060,000 | -31.5% | 86,799 | -51.6% | 3.92% | +14.7% |
| Q2 2016 | $13,230,000 | -12.6% | 179,370 | -33.3% | 3.42% | +18.3% |
| Q1 2016 | $15,140,000 | -30.3% | 269,108 | -16.4% | 2.89% | -5.1% |
| Q4 2015 | $21,725,000 | +73.4% | 321,815 | +19.2% | 3.04% | +82.8% |
| Q3 2015 | $12,528,000 | -24.6% | 270,063 | -12.7% | 1.67% | +4.3% |
| Q2 2015 | $16,620,000 | +83.0% | 309,217 | +63.1% | 1.60% | +97.6% |
| Q1 2015 | $9,084,000 | – | 189,543 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |